CHU Dijon Bourgogne
Dijon, 21079, France
NCT Number: NCT02859090
It has recently been shown that various HSPs are strongly expressed in B lymphomas. Indeed, HSP90 stabilizes the protein Bcl-6 in diffuse large-cell B lymphomas. Pharmacological inhibition of HSP90 in vitro induced apoptosis in lymphoma cells (Cerchietti et al. Nat. Medicine, 2009, 1369-1376). In addition, HSP110 is strongly expressed in non-Hodgkin lymphomas, and targeting this HSP at the cell surface using specific antibodies could constitute a future therapy (Zappasodi et al. Blood, 2011, 4421-4430). Despite the importance of these proteins in the development of lymphomas, their expression and their role in the activation of normal B lymphocytes and the normal development of germinal centres is not known.
The expression of Heat shock proteins should vary among the different B lymphocyte populations present in the tonsils (naïve B cells, memory B cells, germinal centre B cells).
The aim of this study is to establish an expression profile for heat shock proteins in populations of B lymphocytes in human tonsils
Looking for future studies?
Notify MeAll sexes
Interventional
Not applicable
Dijon, 21079, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Day one
Centre Hospitalier Universitaire Dijon
Other
Single-centre Study of the Expression of Heat Shock Proteins in the Lymphocytes From the Tonsils of Patients With Various Diseases Requiring Tonsillectomy
Acronym: HOTLYMPHO
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07704437
Confusion, Delirium
Split, Split-Dalmatia County, Croatia
View Trial DetailsNCT07675278
Chronic Tonsillitis, Infections
Rawalpindi, Punjab Province, Pakistan
View Trial DetailsNCT07646093
Neurologic Manifestations, Pain
Caracas, Miranda, Venezuela
View Trial DetailsNCT07558044
Adenotonsillectomy, Neurologic Manifestations
Caracas, Miranda, Venezuela
View Trial Details